Axitinib Impurity N |
|
| Synonyms: N-Hydroxymethyl Axitinib;N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-[N-hydroxymethyl, 1H-indazol-6-yl-thio]]-benzamide;(E)-2-((1-(hydroxymethyl)-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide. | |
| Cat. No.: A86014 | CAS No.: N.A. |
| MDL.: | Formula: C23H20N4O2S |
| F.W.416.5 | Purity: 99% |
| Storage: | |
|   | |
| Catalog Number: | A86014 | CAS No.: | N.A. | |
| MDL: | Formula: | C23H20N4O2S | ||
| F.W.: | 416.5 | Purity: | 99% | |
| Package: | Unit: | |||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Category: | Reference Standard | ||
| Reference: | Wasser, K., et al.: Eur. Radiol., 13, 80 (2003); Park, J., et al.: Clin. Cancer Res., 8, 1172 (2002); Bergers, G., et al.: J. Clin. Invest., 111, 1287 (2003); | |||
| Application: | N-Hydroxymethyl Axitinib is an impurity of Axitinib, a tyrosine kinase inhibitor used in cancer therapy. | |||
| Category: | Aromatics, Impurities & Metabolites, Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors, | |||








